CAR T: HOPE FOR CANCER PATIENTS WORLDWIDE

International patients can receive CAR-T cell therapy in several countries, including the United States, Canada, Germany, France, Spain, the United Kingdom, Italy, Israel, Australia, China, and Singapore.

These countries have established treatment centers and offer FDA-approved CAR-T therapy for various conditions, such as B cell acute lymphoblastic leukemia, certain B cell lymphoma subtypes, mantle cell lymphoma, and multiple myeloma.

While the availability of CAR-T cell therapy is expanding, some countries are still in the process of adopting and funding these treatments, and access may vary based on individual needs and circumstances.

Sources: